FDA Panel: Newer birth control medications should carry stronger safety warnings.

NBC Nightly News (12/8, story 7, 2:20, Williams) reported, “Medical experts have been taking…[a] look at Drospirenone/Ethinyl Estradiol [Yaz], because of studies that show they may be more likely to cause dangerous blood clots than older versions of the” medication. Chief Medical Editor Dr. Nancy Snyderman said, “Two of the most popular birth control” medications…

HCG weight loss agents pulled by FDA

Over the counter weight loss products containing human chorionic gonadotropin (HCG) have been declared fraudulent and illegal by the FDA and the Federal Trade Commission. The agencies have told seven manufacturers to stop selling them. The warning letters sent t manufacturers note that HCG has not received FDA approval for any weight-loss indication. It has…

Fosamax Duration of Use Questioned by FDA

In September, The FDA’s Reproductive Health Drugs Advisory Committee and the Drug safety and Risk Management Advisory Committee held a joint meeting to discuss the appropriate duration of use for Fosamax and other bisphosphonates. Earlier this year the FDA required manufacturers to include language in their labels stating that the optimal duration for patient use…